Thazhath SS, Marathe CS, Wu T et al (2016) The glucagon-like peptide 1 receptor agonist exenatide inhibits small intestinal motility, flow, transit, and absorption of glucose in healthy subjects and patients with type 2 diabetes: a randomized controlled trial
Hematologic Megaloblastic anemia: pallor, fatigue, weakness Glossitis (beefy red tongue) Jaundice (mild, due to ineffective erythropoiesis) Pancytopenia (in severe cases) 2
Supplement Category Disclaimer : LeviaPatch is classified and regulated as a dietary supplement under DSHEA - not as a pharmaceutical drug
Angelica oil restores the intestinal barrier function by suppressing S100A8/A9 signalling in mice with ulcerative colitis
"High protein, smaller portions, and functional food innovation will be necessary," he said